Initiating peanut oral immunotherapy in peanut-allergic children under age four may be more effective: long term study
Study illustrates links between DNA repair and a rare neurodegenerative disease
20 January 2022Russia sees record daily virus cases amid Omicron surge
21 January 2022Initiating peanut oral immunotherapy in peanut-allergic children under age four may be more effective: long term study
The majority of young children treated with peanut immunotherapy achieved desensitization after two and a half years of treatment, and one in five remained in remission 26 weeks after treatment ended, according to a randomized controlled trial published in The Lancet.
